These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37295474)

  • 61. Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions.
    Caballero ML; Krantz MS; Quirce S; Phillips EJ; Stone CA
    J Allergy Clin Immunol Pract; 2021 Aug; 9(8):2968-2982. PubMed ID: 33737254
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Successful mRNA COVID-19 vaccination in a patient with a history of severe polyethylene glycol anaphylaxis.
    Li DH; Lee E; Song C
    Allergy Asthma Clin Immunol; 2022 Jun; 18(1):57. PubMed ID: 35725661
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience.
    Arroliga ME; Dhanani K; Arroliga AC; Huddleston PS; Trahan J; Aguilar T; Weldon D
    Allergy Asthma Proc; 2021 Sep; 42(5):395-399. PubMed ID: 34474708
    [No Abstract]   [Full Text] [Related]  

  • 64. Hypersensitivity reactions to vaccines in children: from measles to SARS-CoV-2.
    Caffarelli C; Liotti L; Bianchi A; Bottau P; Caimmi S; Crisafulli G; Franceschini F; Paglialunga C; Saretta F; Mori F
    Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):58-60. PubMed ID: 35080320
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management.
    Luxi N; Giovanazzi A; Arcolaci A; Bonadonna P; Crivellaro MA; Cutroneo PM; Ferrajolo C; Furci F; Guidolin L; Moretti U; Olivieri E; Petrelli G; Zanoni G; Senna G; Trifirò G
    BioDrugs; 2022 Jul; 36(4):443-458. PubMed ID: 35696066
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity.
    Worm M; Alexiou A; Bauer A; Treudler R; Wurpts G; Dickel H; Buhl T; Müller S; Jung A; Brehler R; Fluhr J; Klimek L; Mülleneisen N; Pfützner W; Raap U; Roeseler S; Schuh S; Timmermann H; Heine G; Wedi B; Brockow K
    Allergy; 2022 Nov; 77(11):3426-3434. PubMed ID: 35722723
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics.
    Otani IM; Tsao LR; Tang M
    Ann Allergy Asthma Immunol; 2022 Jul; 129(1):88-94.e1. PubMed ID: 35288274
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine.
    Maron JS; Conroy M; Naranbai V; Samarakoon U; Motazedi T; Farmer JR; Freeman E; Banerji A; Bartsch YC; Gregory DJ; Poznansky MC; Alter G; Blumenthal KG
    J Infect Dis; 2022 Sep; 226(7):1231-1236. PubMed ID: 35325158
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy.
    Inoue S; Igarashi A; Morikane K; Hachiya O; Watanabe M; Kakehata S; Sato S; Ueno Y
    Respir Investig; 2022 Mar; 60(2):248-255. PubMed ID: 34920980
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Allergic Reactions After the Administration of COVID-19 Vaccines.
    Bian S; Li L; Wang Z; Cui L; Xu Y; Guan K; Zhao B
    Front Public Health; 2022; 10():878081. PubMed ID: 35655467
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 72. mRNA COVID-19 Vaccine Anaphylaxis: Epidemiology, Risk Factors, and Evaluation.
    Jaggers J; Wolfson AR
    Curr Allergy Asthma Rep; 2023 Mar; 23(3):195-200. PubMed ID: 36689047
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Risk stratification through allergy history: single-centre experience of specialized COVID-19 vaccine clinic.
    Lyons D; Murray C; Hannigan S; Sui J; Alamin S; Conlon N; Keogan M; Khalib K; Fitzpatrick C; O'B Hourihane J; Carey M; Edgar JDM
    Clin Exp Immunol; 2022 Aug; 209(2):182-187. PubMed ID: 35753019
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Consensus document on the approach to children with allergic reactions after vaccination or allergy to vaccine components.
    Echeverría-Zudaire LA; Ortigosa-del Castillo L; Alonso-Lebrero E; Álvarez-García FJ; Cortés-Álvarez N; García-Sánchez N; Martorell-Aragonés A
    Allergol Immunopathol (Madr); 2015; 43(3):304-25. PubMed ID: 25891956
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper.
    Klimek L; Jutel M; Akdis CA; Bousquet J; Akdis M; Torres MJ; Agache I; Canonica GW; Del Giacco S; O'Mahony L; Shamji MH; Schwarze J; Untersmayr E; Ring J; Bedbrook A; Worm M; Zuberbier T; Knol E; Hoffmann-Sommergruber K; Chivato T
    Allergy; 2021 Jun; 76(6):1624-1628. PubMed ID: 33378789
    [TBL] [Abstract][Full Text] [Related]  

  • 76. COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.
    Peter J
    S Afr Med J; 2021 Feb; 111(4):291-294. PubMed ID: 33944757
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Reasons for allergology consultations prior to COVID-19 vaccination and their outcomes : Two-year experience of an allergy center in North Rhine-Westphalia].
    Leonidou Floruß E; Demidova A; Hofmann SC; Balakirski G
    Dermatologie (Heidelb); 2023 Jul; 74(7):511-519. PubMed ID: 37140637
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.
    Desai AP; Desai AP; Loomis GJ
    Vaccine; 2021 Jul; 39(32):4407-4409. PubMed ID: 34215453
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance.
    Stehlin F; Mahdi-Aljedani R; Canton L; Monzambani-Banderet V; Miauton A; Girard C; Kammermann K; Meylan S; Ribi C; Harr T; Yerly D; Muller YD
    Front Allergy; 2022; 3():818049. PubMed ID: 36238929
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine.
    Labella M; Céspedes JA; Doña I; Shamji MH; Agache I; Mayorga C; Torres MJ
    Allergy; 2022 Jul; 77(7):2067-2079. PubMed ID: 34689351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.